Akio Imanishi

581 total citations
21 papers, 463 citations indexed

About

Akio Imanishi is a scholar working on Gastroenterology, Molecular Biology and Surgery. According to data from OpenAlex, Akio Imanishi has authored 21 papers receiving a total of 463 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Gastroenterology, 7 papers in Molecular Biology and 6 papers in Surgery. Recurrent topics in Akio Imanishi's work include Gastroesophageal reflux and treatments (7 papers), Helicobacter pylori-related gastroenterology studies (6 papers) and Ion Transport and Channel Regulation (3 papers). Akio Imanishi is often cited by papers focused on Gastroesophageal reflux and treatments (7 papers), Helicobacter pylori-related gastroenterology studies (6 papers) and Ion Transport and Channel Regulation (3 papers). Akio Imanishi collaborates with scholars based in Japan, United Kingdom and United States. Akio Imanishi's co-authors include Nobuhiro Inatomi, Keizo Hirase, Yasuyoshi Arikawa, Haruyuki Nishida, Yasunobu Hori, Masahiro Kajino, Jun Matsukawa, Yasuhiro Tsukimi, Naoki Tarui and Terufumi Takagi and has published in prestigious journals such as Journal of Medicinal Chemistry, Medicine & Science in Sports & Exercise and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Akio Imanishi

21 papers receiving 447 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Akio Imanishi Japan 9 234 220 116 94 89 21 463
Keizo Hirase Japan 6 217 0.9× 200 0.9× 98 0.8× 93 1.0× 63 0.7× 7 359
Yasunobu Hori Japan 8 415 1.8× 398 1.8× 107 0.9× 172 1.8× 87 1.0× 11 627
Majid Vakily United States 13 263 1.1× 262 1.2× 26 0.2× 44 0.5× 49 0.6× 20 505
Yechan Kim South Korea 11 85 0.4× 49 0.2× 312 2.7× 33 0.4× 25 0.3× 21 503
Syed Hashmi United States 9 76 0.3× 127 0.6× 38 0.3× 23 0.2× 23 0.3× 25 296
Tomoki Yoneyama Japan 9 348 1.5× 331 1.5× 11 0.1× 160 1.7× 72 0.8× 24 545
Pascal Druzgala United States 11 58 0.2× 82 0.4× 28 0.2× 25 0.3× 106 1.2× 24 456
Simone Spada Italy 8 55 0.2× 76 0.3× 94 0.8× 4 0.0× 43 0.5× 15 225
Geun Seog Song South Korea 13 285 1.2× 295 1.3× 5 0.0× 153 1.6× 36 0.4× 28 450
Martin Jäger Germany 12 187 0.8× 8 0.0× 53 0.5× 113 1.2× 121 1.4× 24 473

Countries citing papers authored by Akio Imanishi

Since Specialization
Citations

This map shows the geographic impact of Akio Imanishi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akio Imanishi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akio Imanishi more than expected).

Fields of papers citing papers by Akio Imanishi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akio Imanishi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akio Imanishi. The network helps show where Akio Imanishi may publish in the future.

Co-authorship network of co-authors of Akio Imanishi

This figure shows the co-authorship network connecting the top 25 collaborators of Akio Imanishi. A scholar is included among the top collaborators of Akio Imanishi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akio Imanishi. Akio Imanishi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Furukawa, Hideki, Hiroshi Kohara, Koki Nishimura, et al.. (2023). The mechanism of thrombocytopenia caused by cholesterol-conjugated antisense oligonucleotides. Toxicology in Vitro. 89. 105569–105569. 5 indexed citations
2.
Kamo, Izumi, Hiroshi Nagata, Akio Imanishi, et al.. (2021). Increasing Effects of Selective 5-Hydroxytryptamine Type 2C Receptor Stimulation on Evoked Momentary Urethral Closure in Female Rats and Humans. Journal of Pharmacology and Experimental Therapeutics. 378(2). 60–68. 3 indexed citations
3.
Bajaj, Piyush, Git Chung, Tomoya Yukawa, et al.. (2020). Freshly isolated primary human proximal tubule cells as an in vitro model for the detection of renal tubular toxicity. Toxicology. 442. 152535–152535. 22 indexed citations
4.
Miyazaki, T., Masanori Kawasaki, Atsushi Suzuki, et al.. (2019). Discovery of novel 4-phenyl-2-(pyrrolidinyl)nicotinamide derivatives as potent Nav1.1 activators. Bioorganic & Medicinal Chemistry Letters. 29(6). 815–820. 4 indexed citations
5.
Nishida, Haruyuki, Ikuo Fujimori, Yasuyoshi Arikawa, et al.. (2017). Exploration of pyrrole derivatives to find an effective potassium-competitive acid blocker with moderately long-lasting suppression of gastric acid secretion. Bioorganic & Medicinal Chemistry. 25(13). 3447–3460. 8 indexed citations
6.
Imaeda, Toshihiro, Koji Ono, Kazuo Nakai, et al.. (2017). Discovery, synthesis, and structure-activity relations of 3,4-dihydro-1H-spiro(naphthalene-2,2′-piperidin)-1-ones as potassium-competitive acid blockers. Bioorganic & Medicinal Chemistry. 25(14). 3719–3735. 10 indexed citations
7.
Nishida, Haruyuki, Yasuyoshi Arikawa, Keizo Hirase, et al.. (2017). Identification of a novel fluoropyrrole derivative as a potassium-competitive acid blocker with long duration of action. Bioorganic & Medicinal Chemistry. 25(13). 3298–3314. 7 indexed citations
8.
Suzuki, Yoshio, Tomomi Shimizu, Kenji Sato, et al.. (2015). Different training status may alter the continuous blood glucose kinetics in self-paced endurance running. Experimental and Therapeutic Medicine. 10(3). 978–982. 3 indexed citations
9.
Arikawa, Yasuyoshi, Atsushi Hasuoka, Haruyuki Nishida, et al.. (2015). Synthetic studies of five-membered heteroaromatic derivatives as potassium-competitive acid blockers (P-CABs). Bioorganic & Medicinal Chemistry Letters. 25(10). 2037–2040. 6 indexed citations
10.
Tanaka, Takahiro, Akiko Tanaka, Akihiro Nakamura, et al.. (2012). Effects of TAK-480, a Novel Tachykinin NK2^|^ndash;Receptor Antagonist, on Visceral Hypersensitivity in Rabbits and Ricinoleic Acid^|^ndash;Induced Defecation in Guinea Pigs. Journal of Pharmacological Sciences. 120(1). 15–25. 11 indexed citations
11.
Nishida, Haruyuki, Atsushi Hasuoka, Yasuyoshi Arikawa, et al.. (2012). Discovery, synthesis, and biological evaluation of novel pyrrole derivatives as highly selective potassium-competitive acid blockers. Bioorganic & Medicinal Chemistry. 20(12). 3925–3938. 42 indexed citations
12.
Inatomi, Nobuhiro, Yasushi Fujioka, Hidenori Kamiguchi, et al.. (2012). Establishment and Validation of a Rabbit Model for In Vivo Pharmacodynamic Screening of Tachykinin NK2 Antagonists. Journal of Pharmacological Sciences. 118(4). 487–495. 4 indexed citations
13.
Arikawa, Yasuyoshi, Haruyuki Nishida, Osamu Kurasawa, et al.. (2012). Discovery of a Novel Pyrrole Derivative 1-[5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine Fumarate (TAK-438) as a Potassium-Competitive Acid Blocker (P-CAB). Journal of Medicinal Chemistry. 55(9). 4446–4456. 128 indexed citations
14.
Shimizu, Tomomi, Akio Imanishi, Nobuaki Takeda, et al.. (2011). [Sequential changes in inflammatory and stress responses during 24-hour running].. PubMed. 59(10). 930–5. 3 indexed citations
15.
Nakamura, Akihiro, et al.. (2011). Bidirectional Regulation of Human Colonic Smooth Muscle Contractility by Tachykinin NK2 Receptors. Journal of Pharmacological Sciences. 117(2). 106–115. 18 indexed citations
16.
Shirai, Junya, Hideyuki Sugiyama, Shinji Morimoto, et al.. (2011). Novel 3-phenylpiperidine-4-carboxamides as highly potent and orally long-acting neurokinin-1 receptor antagonists with reduced CYP3A induction. Bioorganic & Medicinal Chemistry. 20(2). 962–977. 1 indexed citations
17.
Hori, Yasunobu, Akio Imanishi, Jun Matsukawa, et al.. (2010). 1-[5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine Monofumarate (TAK-438), a Novel and Potent Potassium-Competitive Acid Blocker for the Treatment of Acid-Related Diseases. Journal of Pharmacology and Experimental Therapeutics. 335(1). 231–238. 164 indexed citations
18.
Suzuki, Masato, et al.. (2006). Effects of Aging on the Renal Function after Physical Exercise. Medicine & Science in Sports & Exercise. 38(Supplement). S89–S89. 5 indexed citations
19.
Nishiyama, Akihiro, et al.. (2005). Risk factors for coronary artery sclerosis in patients with diabetes.. PubMed. 10(2). 108–10. 1 indexed citations
20.
Ohta, Makoto, Makoto Ohara, Shoji Saito, et al.. (2005). [Clinical biochemical evaluation of central fatigue with 24-hour continuous exercise].. PubMed. 53(9). 802–9. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026